Sources

Every source we cite, grouped by tracker page.

AI help for reading mammograms

• Hernström et al., The Lancet Digital Health (2025): MASAI screening performance (Peer-reviewed randomised trial)
• Gommers et al., The Lancet (2026): MASAI interval cancer results (Peer-reviewed randomised trial)
• Editorial: AI for mammography, The Lancet Digital Health (Editorial)
• ClinicalTrials.gov NCT04838756 (Trial registry)

AI that predicts five-year breast cancer risk from a mammogram

• FDA De Novo database: DEN240047 (Allix5) (Regulator)
• FDA De Novo grant letter (PDF) (Regulator)
• FDA decision summary (PDF) (Regulator)

AI that double-checks chest X-rays

• I-MED Radiology: Annalise CXR implementation (2021) (Company document (claim))
• FDA 510(k) database: K222179 (Annalise Enterprise CXR Triage Trauma) (Regulator)
• FDA 510(k) letter K222179 (PDF) (Regulator)
• harrison.ai: FDA 510(k) clearance announcement (Company document (claim))
• Real-world observational study (PMC8689166) (Peer-reviewed observational study)

AI during colonoscopy, and the 'deskilling' question

• FDA De Novo DEN200055 (GI Genius) (Regulator)
• Budzyń et al., Lancet Gastroenterology & Hepatology (2025) (Peer-reviewed observational study)
• American College of Gastroenterology summary (Professional body summary)
• EurekAlert! press release (Press release (claim))
• Hassan et al., Gastrointestinal Endoscopy (2021): meta-analysis of randomised trials (Peer-reviewed meta-analysis)

An AI-designed drug for lung scarring (rentosertib)

• Xu et al., Nature Medicine (2025) (Peer-reviewed randomised trial)
• PubMed 40461817 (Abstract)
• ClinicalTrials.gov NCT05938920 (Trial registry)
• Insilico Medicine announcement (Company document (claim))

AlphaFold 3: predicting how the molecules of life fit together

• Abramson et al., Nature (2024) (Peer-reviewed study)
• Nobel Prize in Chemistry 2024 press release (Official)
• FoldBench benchmarking, Nature Communications (Peer-reviewed study)

Delphi-2M: AI that forecasts risk of 1,000+ diseases

• Shmatko et al., Nature (2025) (Peer-reviewed study)
• Open-access version (PMC12589094) (Peer-reviewed study)
• VVSOR blog critique (Expert commentary)

AMIE: Google's diagnostic chatbot research

• Tu et al., Nature (2025) (Peer-reviewed study)

Microsoft's MAI-DxO: AI 'panel of doctors' on hard cases

• Nori et al., arXiv preprint (2025) (Preprint (not peer-reviewed))
• Microsoft AI: The path to medical superintelligence (Company document (claim))

Generative AI designs new antibiotics against superbugs

• Krishnan et al., Cell (2025) (Peer-reviewed study)
• PubMed 40816267 (Abstract)
• MIT News (University news)

DERM: AI skin-lesion triage that can send some likely-harmless moles off the urgent cancer pathway

• NICE news: conditional NHS recommendation (May 2025) (Official)
• Skin Analytics: Class III CE mark announcement (Feb 2025) (Company document (claim))
• Skin Analytics: certifications page (Company document (claim))
• NICE MIB311: regulatory information (DERM UKCA Class IIa) (Official)
• Evaluation of DERM skin cancer community diagnostic hub (NIHR-hosted report, 2025) (Service evaluation report)

ArteraAI Prostate: AI that reads biopsy slides to forecast prostate cancer outcomes

• FDA De Novo database: DEN240068 (Regulator)
• FDA De Novo grant letter (PDF) (Regulator)
• FDA decision summary (PDF) (Regulator)
• Artera press release (Press release (claim))
• Artera press release: CE marking (21 Apr 2026) (Press release (claim))

AI stethoscopes in GP surgeries: what a 205-practice NHS trial found

• The Lancet: TRICORDER trial (Peer-reviewed randomised trial)
• ClinicalTrials.gov: NCT05987670 (Trial registry)
• Imperial College London news (29 January 2026) (University news)
• BMJ Open: TRICORDER protocol (2025) (Peer-reviewed protocol)
• FDA 510(k) K233409: Eko Low Ejection Fraction Tool (Regulator)
• FDA 510(k) K213794: Eko Murmur Analysis Software (PDF) (Regulator)

AI scribes that write up your appointment: the first randomised trials

• NEJM AI: Ambient AI Scribes in Clinical Practice: A Randomized Trial (Peer-reviewed randomised trial)
• PubMed 41497288: UCLA trial abstract (Abstract)
• NEJM AI: pragmatic RCT of ambient AI and practitioner well-being (Peer-reviewed randomised trial)
• PubMed 41625485: Wisconsin trial abstract (Abstract)

AlphaGenome: AI that predicts how DNA changes might affect gene activity (research tool)

• Nature: Advancing regulatory variant effect prediction with AlphaGenome (Peer-reviewed study)
• Nature Structural & Molecular Biology: News & Views (Expert commentary)

AMIE: Google's research chatbot tested with real patients before GP visits

• Brodeur et al., The Lancet (2026), DOI (Peer-reviewed study)
• PubMed abstract and declaration of interests (PMID 42849491) (Abstract)
• ClinicalTrials.gov NCT06911398 (Trial registry)
• Authors' preprint, arXiv:2603.08448 (March 2026) (Preprint (not peer-reviewed))
• Google blog announcement (Company document (claim))
• Google Research blog (Company document (claim))

AI eye screening in Tanzania: more people reached the eye clinic

• Cleland et al., Lancet Global Health (2026), DOI (Peer-reviewed randomised trial)
• PubMed abstract and declaration of interests (PMID 42863478) (Abstract)
• ISRCTN18317152 (Trial registry)
• LSHTM ICEH news release (University news)
• Cleland et al., trial protocol, BMJ Open (2024) (Peer-reviewed protocol)
• Cleland et al., implementing AI screening in Tanzania, Trans R Soc Trop Med Hyg (2024) (Peer-reviewed study)
• Scoping review of ophthalmic AI medical devices, npj Digital Medicine (2025), Table 1 (Peer-reviewed review (regulatory status))

UK accepts all 44 recommendations on regulating medical AI

• GOV.UK / MHRA press release, 6 Oct 2026 (Official)
• Government response to the National Commission (Official)
• National Commission recommendations report (Official)
• AI Airlock Phase 3 application (Regulator)